The Global Biopharmaceuticals Excipients Market was valued at USD 2.74 Billion in 2024 and is projected to reach USD 4.31 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period (2024–2030). This robust growth is driven by the expanding biologics pipeline, increasing demand for novel drug delivery systems, and stringent regulatory requirements for drug safety and efficacy.

As the biopharmaceutical sector advances toward more sophisticated and targeted therapies, the critical role of excipients—the inactive ingredients that ensure stability, bioavailability, and patient compliance—is gaining prominence. In this blog, we profile the Top 10 Companies in the Biopharmaceuticals Excipients Industry, a group of chemical giants and specialty manufacturers shaping the future of drug formulation.

Download FREE Sample Report: Biopharmaceuticals Excipients Market – View in Detailed Research Report

---

🔟 1. Dow Chemical Company

Headquarters: Midland, Michigan, USA
Key Offering: Methocel™ (HPMC), Ethocel™ (Ethylcellulose), Polyox™ (Polyethylene Oxide)

Dow is a global leader in providing high-performance excipients for controlled-release and solubility enhancement applications. Their portfolio of cellulose-based polymers is essential for formulating solid oral dosage forms, particularly for poorly soluble active pharmaceutical ingredients (APIs).

Innovation Initiatives:

• Development of tailored polymers for hot-melt extrusion and 3D printing of pharmaceuticals

• Investment in sustainable and bio-based raw material sourcing

• Expansion of application support laboratories for customer collaboration

---

9️⃣ 2. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Kollidon® (Povidone), Kollicoat® (Polyvinyl Derivatives), Lutrol® (Poloxamers)

BASF offers one of the industry’s broadest portfolios of excipients for various dosage forms. Their products are critical for solubility enhancement, film coating, and controlled drug release, serving both small molecule and biologic drug developers.

Innovation Initiatives:

• Focus on developing excipients for complex generics and biosimilars

• Digital tools for formulation prediction and optimization

• Strong regulatory support and global supply chain infrastructure

---

8️⃣ 3. Roquette Frères

Headquarters: Lestrem, France
Key Offering: Lycatab® (Starch), Kleptose® (Cyclodextrins), Pearlitol® (Mannitol)

Roquette is a leading player in plant-based excipients, specializing in carbohydrates and starch derivatives. The company is a key supplier of fillers, diluents, and specialty excipients for oral solid dosage forms and biopharmaceutical applications.

Innovation Initiatives:

• Pioneering work in cyclodextrins for solubility enhancement of biologics

• Investment in green chemistry and sustainable production processes

• Development of co-processed excipients for direct compression

Download FREE Sample Report: Biopharmaceuticals Excipients Market – View in Detailed Research Report

---

7️⃣ 4. Ashland Global Holdings Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Benecel™ (HPMC), Klucel™ (Hydroxypropylcellulose), Plasdone™ (Povidone)

Ashland provides a comprehensive range of pharmaceutical polymers and excipients for drug formulation. Their products are widely used in controlled-release systems, tablet coatings, and taste-masking applications.

Innovation Initiatives:

• Advanced functionality excipients for challenging API formulations

• Expansion in high-growth markets through strategic acquisitions

• Focus on excipients for biopharmaceuticals and cell therapies

---

6️⃣ 5. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Eudragit® (Methacrylate Copolymers), Resomer® (Biodegradable Polymers)

Evonik is a specialty chemicals company with a strong focus on functional polymers for pharmaceutical applications. Their Eudragit brand is the industry standard for enteric coating and controlled drug release systems.

Innovation Initiatives:

• Development of lipids and polymers for mRNA vaccine delivery systems

• Investment in continuous manufacturing technologies for excipients

• Expansion of drug delivery services and partnership models

---

5️⃣ 6. Shin-Etsu Chemical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Pharmacoat® (HPMC), Ceolus™ (Microcrystalline Cellulose)

Shin-Etsu is a leading manufacturer of cellulose-based excipients with a strong presence in the Asian market. The company’s high-purity excipients are essential for tablet formulation and film coating applications.

Innovation Initiatives:

• Development of specialty cellulose derivatives for niche applications

• Expansion of production capacity to meet growing global demand

• Focus on quality consistency and regulatory compliance

---

4️⃣ 7. Lubrizol Corporation

Headquarters: Wickliffe, Ohio, USA
Key Offering: Carbopol® (Polyacrylic Acid), Pemulen™ (Polymer Emulsifiers)

Lubrizol specializes in advanced polymer technologies for pharmaceutical and healthcare applications. Their excipients are critical for topical formulations, controlled-release systems, and bioavailability enhancement.

Innovation Initiatives:

• Development of novel excipients for complex drug delivery systems

• Focus on sustainability through bio-based and biodegradable polymers

• Expansion in emerging markets through local manufacturing

---

3️⃣ 8. JRS Pharma

Headquarters: Rosenberg, Germany
Key Offering: Vivapur® (Microcrystalline Cellulose), Vivasol® (Sodium Starch Glycolate)

JRS Pharma is a specialist in plant-derived excipients, particularly cellulose and starch-based products. The company focuses on providing high-quality functional excipients for the global pharmaceutical industry.

Innovation Initiatives:

• Development of co-processed excipients for improved functionality

• Expansion of product portfolio for biopharmaceutical applications

• Investment in application technology and customer support

Download FREE Sample Report: Biopharmaceuticals Excipients Market – View in Detailed Research Report

---

2️⃣ 9. MEGGLE Group

Headquarters: Wasserburg, Germany
Key Offering: Tablettose® (Lactose), Meggle Excipients (Various)

MEGGLE is a leading manufacturer of pharmaceutical lactose and specialty excipients. The company’s products are essential for tablet formulation, particularly in direct compression applications.

Innovation Initiatives:

• Development of lactose grades for specific formulation needs

• Focus on consistency and quality in excipient manufacturing

• Expansion of product portfolio for inhalational formulations

---

1️⃣ 10. ABITEC Corporation

Headquarters: Columbus, Ohio, USA
Key Offering: Captex® (Triglycerides), Capmul® (Monoglycerides)

ABITEC specializes in lipid-based excipients for solubility enhancement and bioavailability improvement. Their products are critical for formulating poorly soluble drugs and lipid-based delivery systems.

Innovation Initiatives:

• Development of lipid systems for oral and injectable formulations

• Focus on excipients for advanced drug delivery technologies

• Custom lipid solutions for specific API challenges

Get Full Report Here: Biopharmaceuticals Excipients Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Biopharmaceuticals Excipients Is Functional and Smart

The biopharmaceuticals excipients market is undergoing a significant transformation. While traditional excipients continue to dominate in volume, the industry is increasingly focused on functional excipients that actively contribute to drug performance, stability, and targeted delivery.

📈 Key Trends Shaping the Market:

• Rising demand for biologics and biosimilars driving need for specialized stabilizers

• Growing importance of co-processed excipients for simplified formulations

• Increasing regulatory scrutiny and quality requirements for excipient safety

• Expansion of continuous manufacturing requiring specialized excipient properties

Get Full Report Here: Biopharmaceuticals Excipients Market – View in Detailed Research Report

The companies listed above are not only supplying essential formulation components—they’re driving the innovation ecosystem that enables the development of next-generation therapeutics.